The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Preimplantation Genetics Diagnosis (PGD)-Global Market Insights and Sales Trends 2024

Preimplantation Genetics Diagnosis (PGD)-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1845038

No of Pages : 104

Synopsis
The global Preimplantation Genetics Diagnosis (PGD) market size is expected to reach US$ 127.4 million by 2029, growing at a CAGR of 3.5% from 2023 to 2029. The market is mainly driven by the significant applications of Preimplantation Genetics Diagnosis (PGD) in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Preimplantation Genetics Diagnosis (PGD) market. Gender Selection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Chromosomal Abnormalities segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Preimplantation Genetics Diagnosis (PGD) market, driven by demand from China, the second largest economy with some signs of stabilising, the Preimplantation Genetics Diagnosis (PGD) market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Preimplantation Genetics Diagnosis (PGD), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Preimplantation Genetics Diagnosis (PGD) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Preimplantation Genetics Diagnosis (PGD) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Preimplantation Genetics Diagnosis (PGD) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Preimplantation Genetics Diagnosis (PGD) covered in this report include Abbott Laboratories, Natera, Inc, PerkinElmer, Illumina, F. Hoffmann-La Roche, Thermo Fisher Scientific, Laboratory Corporation of America Holdings, Agilent Technologies and Quest Diagnostics Incorporated, etc.
The global Preimplantation Genetics Diagnosis (PGD) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Natera, Inc
PerkinElmer
Illumina
F. Hoffmann-La Roche
Thermo Fisher Scientific
Laboratory Corporation of America Holdings
Agilent Technologies
Quest Diagnostics Incorporated
Cooper Surgical
Beijing Genomics Institute (BGI)
Genea Limited
Global Preimplantation Genetics Diagnosis (PGD) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Preimplantation Genetics Diagnosis (PGD) market, Segment by Type:
Gender Selection
Chromosomal Abnormalities
Single Gene Disorders
HLA Typing
Aneuploidy
X-Linked Diseases
Others
Global Preimplantation Genetics Diagnosis (PGD) market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Preimplantation Genetics Diagnosis (PGD) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Preimplantation Genetics Diagnosis (PGD)
1.1 Preimplantation Genetics Diagnosis (PGD) Market Overview
1.1.1 Preimplantation Genetics Diagnosis (PGD) Product Scope
1.1.2 Preimplantation Genetics Diagnosis (PGD) Market Status and Outlook
1.2 Global Preimplantation Genetics Diagnosis (PGD) Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Preimplantation Genetics Diagnosis (PGD) Market Size by Region (2018-2029)
1.4 Global Preimplantation Genetics Diagnosis (PGD) Historic Market Size by Region (2018-2023)
1.5 Global Preimplantation Genetics Diagnosis (PGD) Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Preimplantation Genetics Diagnosis (PGD) Market Size (2018-2029)
1.6.1 North America Preimplantation Genetics Diagnosis (PGD) Market Size (2018-2029)
1.6.2 Europe Preimplantation Genetics Diagnosis (PGD) Market Size (2018-2029)
1.6.3 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size (2018-2029)
1.6.4 Latin America Preimplantation Genetics Diagnosis (PGD) Market Size (2018-2029)
1.6.5 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size (2018-2029)
2 Preimplantation Genetics Diagnosis (PGD) Market by Type
2.1 Introduction
2.1.1 Gender Selection
2.1.2 Chromosomal Abnormalities
2.1.3 Single Gene Disorders
2.1.4 HLA Typing
2.1.5 Aneuploidy
2.1.6 X-Linked Diseases
2.1.7 Others
2.2 Global Preimplantation Genetics Diagnosis (PGD) Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Preimplantation Genetics Diagnosis (PGD) Historic Market Size by Type (2018-2023)
2.2.2 Global Preimplantation Genetics Diagnosis (PGD) Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Preimplantation Genetics Diagnosis (PGD) Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Preimplantation Genetics Diagnosis (PGD) Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Preimplantation Genetics Diagnosis (PGD) Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Revenue Breakdown by Type (2018-2029)
3 Preimplantation Genetics Diagnosis (PGD) Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Preimplantation Genetics Diagnosis (PGD) Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Preimplantation Genetics Diagnosis (PGD) Historic Market Size by Application (2018-2023)
3.2.2 Global Preimplantation Genetics Diagnosis (PGD) Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Preimplantation Genetics Diagnosis (PGD) Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Preimplantation Genetics Diagnosis (PGD) Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Preimplantation Genetics Diagnosis (PGD) Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Revenue Breakdown by Application (2018-2029)
4 Preimplantation Genetics Diagnosis (PGD) Competition Analysis by Players
4.1 Global Preimplantation Genetics Diagnosis (PGD) Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Preimplantation Genetics Diagnosis (PGD) as of 2022)
4.3 Date of Key Players Enter into Preimplantation Genetics Diagnosis (PGD) Market
4.4 Global Top Players Preimplantation Genetics Diagnosis (PGD) Headquarters and Area Served
4.5 Key Players Preimplantation Genetics Diagnosis (PGD) Product Solution and Service
4.6 Competitive Status
4.6.1 Preimplantation Genetics Diagnosis (PGD) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Preimplantation Genetics Diagnosis (PGD) Products, Services and Solutions
5.1.4 Abbott Laboratories Preimplantation Genetics Diagnosis (PGD) Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Laboratories Recent Developments
5.2 Natera, Inc
5.2.1 Natera, Inc Profile
5.2.2 Natera, Inc Main Business
5.2.3 Natera, Inc Preimplantation Genetics Diagnosis (PGD) Products, Services and Solutions
5.2.4 Natera, Inc Preimplantation Genetics Diagnosis (PGD) Revenue (US$ Million) & (2018-2023)
5.2.5 Natera, Inc Recent Developments
5.3 PerkinElmer
5.3.1 PerkinElmer Profile
5.3.2 PerkinElmer Main Business
5.3.3 PerkinElmer Preimplantation Genetics Diagnosis (PGD) Products, Services and Solutions
5.3.4 PerkinElmer Preimplantation Genetics Diagnosis (PGD) Revenue (US$ Million) & (2018-2023)
5.3.5 Illumina Recent Developments
5.4 Illumina
5.4.1 Illumina Profile
5.4.2 Illumina Main Business
5.4.3 Illumina Preimplantation Genetics Diagnosis (PGD) Products, Services and Solutions
5.4.4 Illumina Preimplantation Genetics Diagnosis (PGD) Revenue (US$ Million) & (2018-2023)
5.4.5 Illumina Recent Developments
5.5 F. Hoffmann-La Roche
5.5.1 F. Hoffmann-La Roche Profile
5.5.2 F. Hoffmann-La Roche Main Business
5.5.3 F. Hoffmann-La Roche Preimplantation Genetics Diagnosis (PGD) Products, Services and Solutions
5.5.4 F. Hoffmann-La Roche Preimplantation Genetics Diagnosis (PGD) Revenue (US$ Million) & (2018-2023)
5.5.5 F. Hoffmann-La Roche Recent Developments
5.6 Thermo Fisher Scientific
5.6.1 Thermo Fisher Scientific Profile
5.6.2 Thermo Fisher Scientific Main Business
5.6.3 Thermo Fisher Scientific Preimplantation Genetics Diagnosis (PGD) Products, Services and Solutions
5.6.4 Thermo Fisher Scientific Preimplantation Genetics Diagnosis (PGD) Revenue (US$ Million) & (2018-2023)
5.6.5 Thermo Fisher Scientific Recent Developments
5.7 Laboratory Corporation of America Holdings
5.7.1 Laboratory Corporation of America Holdings Profile
5.7.2 Laboratory Corporation of America Holdings Main Business
5.7.3 Laboratory Corporation of America Holdings Preimplantation Genetics Diagnosis (PGD) Products, Services and Solutions
5.7.4 Laboratory Corporation of America Holdings Preimplantation Genetics Diagnosis (PGD) Revenue (US$ Million) & (2018-2023)
5.7.5 Laboratory Corporation of America Holdings Recent Developments
5.8 Agilent Technologies
5.8.1 Agilent Technologies Profile
5.8.2 Agilent Technologies Main Business
5.8.3 Agilent Technologies Preimplantation Genetics Diagnosis (PGD) Products, Services and Solutions
5.8.4 Agilent Technologies Preimplantation Genetics Diagnosis (PGD) Revenue (US$ Million) & (2018-2023)
5.8.5 Agilent Technologies Recent Developments
5.9 Quest Diagnostics Incorporated
5.9.1 Quest Diagnostics Incorporated Profile
5.9.2 Quest Diagnostics Incorporated Main Business
5.9.3 Quest Diagnostics Incorporated Preimplantation Genetics Diagnosis (PGD) Products, Services and Solutions
5.9.4 Quest Diagnostics Incorporated Preimplantation Genetics Diagnosis (PGD) Revenue (US$ Million) & (2018-2023)
5.9.5 Quest Diagnostics Incorporated Recent Developments
5.10 Cooper Surgical
5.10.1 Cooper Surgical Profile
5.10.2 Cooper Surgical Main Business
5.10.3 Cooper Surgical Preimplantation Genetics Diagnosis (PGD) Products, Services and Solutions
5.10.4 Cooper Surgical Preimplantation Genetics Diagnosis (PGD) Revenue (US$ Million) & (2018-2023)
5.10.5 Cooper Surgical Recent Developments
5.11 Beijing Genomics Institute (BGI)
5.11.1 Beijing Genomics Institute (BGI) Profile
5.11.2 Beijing Genomics Institute (BGI) Main Business
5.11.3 Beijing Genomics Institute (BGI) Preimplantation Genetics Diagnosis (PGD) Products, Services and Solutions
5.11.4 Beijing Genomics Institute (BGI) Preimplantation Genetics Diagnosis (PGD) Revenue (US$ Million) & (2018-2023)
5.11.5 Beijing Genomics Institute (BGI) Recent Developments
5.12 Genea Limited
5.12.1 Genea Limited Profile
5.12.2 Genea Limited Main Business
5.12.3 Genea Limited Preimplantation Genetics Diagnosis (PGD) Products, Services and Solutions
5.12.4 Genea Limited Preimplantation Genetics Diagnosis (PGD) Revenue (US$ Million) & (2018-2023)
5.12.5 Genea Limited Recent Developments
6 North America
6.1 North America Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Preimplantation Genetics Diagnosis (PGD) Market Dynamics
11.1 Preimplantation Genetics Diagnosis (PGD) Industry Trends
11.2 Preimplantation Genetics Diagnosis (PGD) Market Drivers
11.3 Preimplantation Genetics Diagnosis (PGD) Market Challenges
11.4 Preimplantation Genetics Diagnosis (PGD) Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’